Moneycontrol PRO
HomeNewsBusinessEconomyCabinet approves parts of Centre’s Rs 20 lakh crore stimulus package

Cabinet approves parts of Centre’s Rs 20 lakh crore stimulus package

Cabinet has approved seven sections of the package

May 21, 2020 / 19:30 IST
X

The Union Cabinet has approved sections of the Centre's Rs 20 lakh crore stimulus package outlined in five tranches by Finance Minister Nirmala Sitharaman over May 13-17.

The Cabinet has approved seven of 54 announcements made, The Economic Times reported. All 54 may not need approval. Among the sections approved includes:

Rs 41,000 crore government support for the MSME credit guarantee scheme for FY21-24: The National Credit Guarantee Trustee Co (NCGTC) to provide 100 percent guarantee coverage in the form of a guaranteed emergency credit line (GECL) facility for micro, small and medium enterprises (MSMEs).

Rs 30,000 crore special liquidity scheme for non-banking finance companies (NBFCs) and housing finance companies (HFCs): As part of the scheme, a Rs 5 crore special purpose vehicle (SPV) will be set up by a large public sector bank to manage a stressed asset fund (SAF), where up to Rs 30,000 crore will be guaranteed by the government and purchased by the Reserve Bank of India (RBI).

For migrants: Rs 3,109 crore subsidy for free distribution of 5 kg of grains to migrants till June.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

For senior citizens: The Pradhan Mantri Vaya Vandana Yojana (PMVVY), a social security scheme for senior citizens, has been extended for three years until March 2023.

New methodology for commercial mining and coal sale: Auctioning of coal blocks on a revenue-share basis approved. It has set a 4 percent revenue share as the base price for bids, with no cap on coal utilisation.

For farmers: Rs 10,000 crore scheme for micro food enterprises, farmer producer organisations (FPOs), self-help groups (SHGs) and cooperatives.

Rs 20,050 crore scheme for fisheries: Cleared and for five years from the current fiscal.

Moneycontrol News
first published: May 21, 2020 04:02 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347